scholarly journals Impact of stigma on HIV treatment seeking behavior among the youth living with HIV and AIDS in sub-Saharan Africa: critical review of literature

2021 ◽  
Vol 20 (2) ◽  
pp. 90-95
Author(s):  
Anthony Kiwanuka ◽  
Eddy Walakira ◽  
Lena Andersson ◽  
David K. Mafigiri
Keyword(s):  
Critical Review ◽  
Hiv Treatment ◽  
Hiv And Aids ◽  
Sub Saharan Africa ◽  
Treatment Seeking ◽  
Review Of Literature ◽  
Seeking Behavior ◽  
Sub Saharan ◽  
Youth Living With Hiv ◽  
Living With Hiv

scholarly journals Management of TB/HIV co-infection: the state of the evidence

2020 ◽  
Vol 54 (3) ◽  
pp. 186-196
Author(s):  
Kwasi Torpey ◽  
Adwoa Agyei-Nkansah ◽  
Lily Ogyiri ◽  
Audrey Forson ◽  
Margaret Lartey ◽  
...  
Keyword(s):  
National Level ◽  
Hiv Treatment ◽  
The State ◽  
Sub Saharan Africa ◽  
People Living With Hiv ◽  
Increased Risk ◽  
Mdr Tb ◽  
Sub Saharan ◽  
Living With Hiv ◽  
Hiv Negative

Tuberculosis (TB) and HIV are strongly linked. There is a 19 times increased risk of developing active TB in people living with HIV than in HIV-negative people with Sub-Saharan Africa being the hardest hit region. According to the WHO, 1.3 million people died from TB, and an additional 300,000 TB-related deaths among people living with HIV. Although some progress has been made in reducing TB-related deaths among people living with HIV due to the evolution of diagnostics, treatment and antiretroviral HIV treatment, multi drug resistant TB is becoming a source of worry. Though significant progress has been made at the national level, understanding the state of the evidence and the challenges will better inform the national response of the opportunities for improved patient outcomes.Keywords: Tuberculosis, management, HIV, MDR TB, GhanaFunding: None

scholarly journals “Lighten This Burden of Ours”: Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya

2021 ◽  
Vol 20 ◽  
pp. 232595822110005
Author(s):  
Jane M. Simoni ◽  
Kristin Beima-Sofie ◽  
George Wanje ◽  
Zahra H. Mohamed ◽  
Kenneth Tapia ◽  
...  
Keyword(s):  
Side Effects ◽  
Treatment Options ◽  
Sub Saharan Africa ◽  
Hiv Stigma ◽  
Attractive Alternative ◽  
Persons Living With Hiv ◽  
Sub Saharan ◽  
Long Acting ◽  
Youth Living With Hiv ◽  
Living With Hiv

Background: Long-acting injectable (LAI) antiretroviral therapy (ART) may offer persons living with HIV (PLWH) an attractive alternative to pill-based treatment options, yet acceptability data remain scant, especially in sub-Saharan Africa. Methods: We conducted 6 focus group discussions with PLWH, including key stake holder groups, and analyzed data with content analysis. Results: Initial reactions to the idea of LAI-ART were often positive. The primary advantages voiced were potential to facilitate improved adherence and alleviate the burden of daily pill-taking while avoiding inadvertent disclosure and HIV stigma. Potential side effects were a particular concern of the women. Most participants preferred clinic-based administration over self-injections at home due to concerns about safety, privacy, and potential need for refrigeration. Conclusions: LAI-ART may be acceptable in Kenya, provided injections are infrequent and delivered in a clinic setting. However, HIV stigma, fear of potential side effects, and limited clinical capacity would need to be addressed.

scholarly journals The Stigmatization of HIV/AIDS Victims in Sub-Saharan Africa and the Gospel

2021 ◽  
Vol 7 (2) ◽  
pp. 185
Author(s):  
PHILLIPUS J. (FLIP) BUYS
Keyword(s):  
Hiv And Aids ◽  
Sub Saharan Africa ◽  
People Living With Hiv ◽  
Community Attitudes ◽  
Large Numbers ◽  
Keywords Hiv ◽  
Shame Culture ◽  
Sub Saharan ◽  
Living With Hiv ◽  
Hiv Aids

One of the most challenging issues in dealing with HIV/AIDS in Africa is breaking through the stigmas surrounding the disease and building resilience in communities where large numbers of people are infected with HIV or otherwise affected by the pandemic. This article explores the relationship between shame, fear, guilt, witchcraft, and HIV/AIDS stigmatization by looking at key features of the African traditional worldview and culture. We point out predominant witchcraft beliefs and how they translate to community attitudes towards people living with HIV and AIDS. We highlight the influence of prevailing beliefs in witchcraft and how they aggravate the experience of fear, shame, and stigmatization by people infected with or otherwise affected by HIV. Relevant aspects of the gospel are brought to bear to answer these challenges. KEYWORDS: HIV/AIDS, stigmatization, shame culture, fear culture, witchcraft, ubuntu

Progress countering HIV/AIDS in Africa may be at risk

2017 ◽  
Keyword(s):  
At Risk ◽  
Hiv Treatment ◽  
Hiv And Aids ◽  
Sub Saharan Africa ◽  
Content Type ◽  
Prevention Services ◽  
Treatment And Prevention ◽  
Budget Support ◽  
Sub Saharan ◽  
Hiv Aids

Significance HIV and AIDS have slipped from the public radar in recent years but nonetheless remains a serious health challenge across sub-Saharan Africa (SSA). Efforts to control the epidemic may well be put at risk following recent US policy announcements that are likely to undermine prevention efforts. Impacts The US Mexico City Policy will damage HIV/AIDS programming through its effects on critical sexual and reproductive health (SRH) services. Growing drug resistance to HIV treatment will impair both treatment and prevention services, leading to increased deaths and new infections. Weak health systems and lack of domestic support jeopardises the sustainability of HIV services. Emerging health crises may divert donor attention and budget support from HIV/AIDS organisations at a time when momentum is needed.

HIV and AIDS, Stigma and Liberation in the Old Testament

Exchange ◽  
2007 ◽  
Vol 36 (2) ◽  
pp. 184-197 ◽  
Author(s):  
Ezra Chitando ◽  
Masiiwa Gunda
Keyword(s):  
Old Testament ◽  
Hebrew Bible ◽  
Hiv And Aids ◽  
Sub Saharan Africa ◽  
People Living With Hiv ◽  
The Bible ◽  
Aids Stigma ◽  
Sub Saharan ◽  
Living With Hiv ◽  
The Church

AbstractAs the HIV and AIDS pandemic continues to affect most parts of Sub-Saharan Africa, the church has attempted to mitigate its effects. Unfortunately, stigma has emerged as a major challenge. The church has been implicated in stigmatizing people living with HIV and AIDS. Some Christians have used the Bible to justify the exclusion of people living with HIV and AIDS. This article examines HIV and AIDS stigma. It highlights the various forms of stigma, alongside exploring the occurrence of stigma in the Hebrew Bible. The study calls for a re-reading of the Hebrew Bible in the context of HIV and AIDS stigma and discrimination. It argues that the theme of liberation that underpins the Hebrew Bible implies that stigma has no place in human relations. The paper draws attention to the need to bring liberation to the heart of mission in the light of HIV and AIDS in Africa.

scholarly journals HIV Treatment in sub-Saharan Africa: Did bureaucratic headwinds delay access to dolutegravir?

2019 ◽  
Author(s):  
Reuben Granich ◽  
Somya Gupta
Keyword(s):  
Service Delivery ◽  
National Level ◽  
Essential Element ◽  
Hiv Treatment ◽  
Sub Saharan Africa ◽  
World Health ◽  
Critical Element ◽  
People Living With Hiv ◽  
Sub Saharan ◽  
Living With Hiv

IntroductionThe World Health Organization now recommends dolutegravir (DTG) as part of the preferred first-line treatment for all adults living with HIV including women who may become pregnant. The new regimen with its high barrier to resistance, shortened time to suppression, superior side effects profile, and lower health sector and individual costs, represents a significant improvement. The recommendation removes an important obstacle to accessing dolutegravir as an essential element in controlling the epidemic. DiscussionTranslating science to policy to HIV service delivery is complex and vulnerable to significant delays. WHO, assuming a regulatory role, used preliminary Botswana Tsepamo study information regarding neural tube defects to issue a “safety signal” regarding DTG in May 2018. Regulatory evaluations of rare adverse reactions are complex, take time, and require considerable subject area specific expertise. After over a year, the WHO reversed its initial findings and issued revised treatment recommendations. However, the mixed messaging and confusion around dolutegravir’s safety profile has delayed national level adoption. The pace of national adoption of new WHO recommendations is measurable through published national guidelines and/or circulars available in the public domain. After 2015, published guidelines for 22 of 46 sub-Saharan countries (94% of 2018 regional HIV burden) showed that only three countries representing 4% of regional burden have adopted the new WHO preferred 1st line recommendations. ConclusionsMonitoring and evaluating the translation of science to service delivery is a critical element of successful disease control and elimination. The DTG false alarm and ongoing delayed access provides an opportunity to learn valuable lessons and implement corrective actions. However, lessons can only be learned by accurately describing and examining the timeline, processes, and impact of policy decisions that can adversely impact millions of people living with HIV. As with any successful global disease elimination effort or major project, it is important to establish a critical pathway for translation of science to service delivery and hold people and agencies accountable for their roles in accelerating and/or delaying progress.

Elderly Grandparents as Caregivers of Children Affected or Infected by HIV and AIDS in Namibia

2020 ◽  
pp. 68-83
Author(s):  
Eveline N. Kalomo ◽  
Simon George Taukeni
Keyword(s):  
Kinship Care ◽  
Hiv And Aids ◽  
Sub Saharan Africa ◽  
Policy And Practice ◽  
Vulnerable Children ◽  
Systematic Theory ◽  
Orphans And Vulnerable Children ◽  
Sub Saharan ◽  
Living With Hiv ◽  
Elderly Caregivers

Kinship care is one of the most prevalent forms of placement that is used for children affected and/or infected by HIV and AIDS in Namibia. However, the literature lacks a systematic theory-informed understanding with respect to what is currently known about caregivers generally and specifically, elderly caregivers of orphans, and vulnerable children (OVC) in sub-Saharan Africa. This foundational chapter attempts to provide readers with content to assist in their understanding of the characteristics, role, and experiences of kinship elderly caregivers of children affected and/or infected by HIV and AIDS. In addition, the chapter highlights what is known about children living with HIV in Namibia. Finally, the chapter offers suggestions for policy and practice.

Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa

2021 ◽  
pp. 095646242110422
Author(s):  
Reuben Granich ◽  
Somya Gupta ◽  
Brian Williams
Keyword(s):  
Human Immunodeficiency Virus ◽  
Viral Suppression ◽  
Hiv Treatment ◽  
Sub Saharan Africa ◽  
People Living With Hiv ◽  
Access To Treatment ◽  
Immunodeficiency Virus ◽  
Sub Saharan ◽  
Living With Hiv ◽  
Hiv Funding

Human immunodeficiency virus (HIV) treatment prevents illness, death, and transmission. The 90-90-90 disease control target is only 73% of people living with HIV virally suppressed. For 2010 to 2019, we abstracted HIV funding data for 40 countries in sub-Saharan Africa (70% of global HIV burden and >99% of HIV burden in the region in 2018). During 2010–2019, there was ∼$52 billion funding for 40 countries (99% Africa HIV burden). Domestic funding ranged from $0 to $3.2 billion. PEPFAR funding was $32 billion (average $1.4 billion; range $0.089–4.3 billion) among 22 countries. Global Fund averaged $306 million ($1.9 million to $1.1 billion) for 40 countries. Among PLHIV, known HIV status averaged 80% (11% to 94%). ART coverage averaged 64% (9% to 90%). Viral suppression among PLHIV ranged from 8% to 87%. Of the 40 countries, 21 reported under 60% of PLHIV to be on treatment and 13 did not report viral suppression for 2018. Achieving 90-90-90 is feasible in challenging settings if resources are used efficiently. Despite the significant investment in the HIV response, many countries have not reached the 90-90-90 target. Greater attention to efficiency and prioritizing important targets will be required to end AIDS in Africa.

Sign in / Sign up

Export Citation Format

Share Document